Cargando…

AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma

BACKGROUND: Lung adenocarcinoma (LUAD), as the main subtype of lung cancer, is one of the common causes of cancer-related deaths worldwide. The AHNAK family is correlated with cell structure and migration, cardiac calcium channel signaling, and tumor metastasis. Previous studies showed AHNAK2 could...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Shusen, Lu, Yuanyuan, Qi, Lei, Wang, Hongyan, Wang, Zhihua, Cai, Zhigang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456490/ https://www.ncbi.nlm.nih.gov/pubmed/32904605 http://dx.doi.org/10.1155/2020/8571932

Ejemplares similares

AHNAKs roles in physiology and malignant tumors
por: Zhang, Shusen, et al.
Publicado: (2023)

FOXM1 and CENPF are associated with a poor prognosis through promoting proliferation and migration in lung adenocarcinoma
por: Li, Peipei, et al.
Publicado: (2023)

AHNAK2 is a biomarker and a potential therapeutic target of adenocarcinomas: AHNAK2 is a biomarker for adenocarcinomas
por: Xu, Meng, et al.
Publicado: (2022)

Upregulation of nucleoprotein AHNAK is associated with poor outcome of pancreatic ductal adenocarcinoma prognosis via mediating epithelial-mesenchymal transition
por: Zhang, Zhiwen, et al.
Publicado: (2019)

Down-Regulation of AHNAK2 Inhibits Cell Proliferation, Migration and Invasion Through Inactivating the MAPK Pathway in Lung Adenocarcinoma
por: Wang, Dong-Wei, et al.
Publicado: (2020)

AHNAK as a Prognosis Factor Suppresses the Tumor Progression in Glioma
por: Zhao, Zijin, et al.
Publicado: (2017)

AHNAK and Inflammatory Markers Predict Poor Survival in Laryngeal Carcinoma
por: Dumitru, Claudia A., et al.
Publicado: (2013)

AHNAK2 Promotes Migration, Invasion, and Epithelial-Mesenchymal Transition in Lung Adenocarcinoma Cells via the TGF-β/Smad3 Pathway
por: Liu, Gang, et al.
Publicado: (2020)

Downregulation of AHNAK2 inhibits cell cycle of lung adenocarcinoma cells by interacting with RUVBL1
por: Li, Xin, et al.
Publicado: (2023)

The Obscure Potential of AHNAK2
por: Zardab, Mohamed, et al.
Publicado: (2022)

AHNAK2 is a potential prognostic biomarker in patients with PDAC
por: Lu, Di, et al.
Publicado: (2017)

DDIT4 overexpression associates with poor prognosis in lung adenocarcinoma
por: Song, Li, et al.
Publicado: (2021)

PIK3CA gene mutation associated with poor prognosis of lung adenocarcinoma
por: Zhang, Lina, et al.
Publicado: (2013)

AHNAK is downregulated in melanoma, predicts poor outcome, and may be required for the expression of functional cadherin-1
por: Sheppard, Hilary M., et al.
Publicado: (2016)

SIRT1 expression is associated with poor prognosis of lung adenocarcinoma
por: Li, Chong, et al.
Publicado: (2015)

CUEDC2 down-regulation is associated with tumor growth and poor prognosis in lung adenocarcinoma
por: Sun, Longhua, et al.
Publicado: (2015)

High GNG4 expression is associated with poor prognosis in patients with lung adenocarcinoma
por: Zhou, Bodong, et al.
Publicado: (2021)

Key microRNAs and hub genes associated with poor prognosis in lung adenocarcinoma
por: Ye, Guan-Chao, et al.
Publicado: (2021)

TOP2A Promotes Lung Adenocarcinoma Cells' Malignant Progression and Predicts Poor Prognosis in Lung Adenocarcinoma
por: Kou, Fan, et al.
Publicado: (2020)

NUF2 Expression Promotes Lung Adenocarcinoma Progression and Is Associated With Poor Prognosis
por: Jiang, Feng, et al.
Publicado: (2022)

Long Noncoding RNA RGMB-AS1 Indicates a Poor Prognosis and Modulates Cell Proliferation, Migration and Invasion in Lung Adenocarcinoma
por: Li, Ping, et al.
Publicado: (2016)

Overexpression of FAM83A Is Associated with Poor Prognosis of Lung Adenocarcinoma
por: Liu, Xin, et al.
Publicado: (2022)

Claudin‐1 correlates with poor prognosis in lung adenocarcinoma
por: Sun, Bing‐sheng, et al.
Publicado: (2016)

Decreased INPP5B expression predicts poor prognosis in lung adenocarcinoma
por: Deng, Jun, et al.
Publicado: (2022)

Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma
por: Li, Mei-Xiang, et al.
Publicado: (2021)

Long non-coding RNA, CHRF, predicts poor prognosis of lung adenocarcinoma and promotes cell proliferation and migration
por: Xie, Xiaowei, et al.
Publicado: (2018)

Decreased expression of JAK1 associated with immune infiltration and poor prognosis in lung adenocarcinoma
por: Cai, Jinlian, et al.
Publicado: (2020)

AHNAK suppresses ovarian cancer progression through the Wnt/β-catenin signaling pathway
por: Cai, Yanlin, et al.
Publicado: (2021)

Coexisting EGFR and TP53 Mutations in Lung Adenocarcinoma Patients Are Associated With COMP and ITGB8 Upregulation and Poor Prognosis
por: Zheng, Chang, et al.
Publicado: (2020)

CIP4 Promotes Lung Adenocarcinoma Metastasis and Is Associated with Poor Prognosis
por: Truesdell, P, et al.
Publicado: (2014)

TGFBI Promoter Methylation is Associated with Poor Prognosis in Lung Adenocarcinoma Patients
por: Seok, Yangki, et al.
Publicado: (2019)

The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma
por: Chen, Aifeng, et al.
Publicado: (2021)

AHNAK Contributes to Hepatocellular Carcinoma Growth by Interacting with IGF-1R
por: Li, Kang, et al.
Publicado: (2022)

BPTF promotes tumor growth and predicts poor prognosis in lung adenocarcinomas
por: Dai, Meng, et al.
Publicado: (2015)

Prognostic Impact of AHNAK2 Expression in Patients Treated with Radical Cystectomy
por: Koguchi, Dai, et al.
Publicado: (2021)

Up-regulation of CKAP2L expression promotes lung adenocarcinoma invasion and is associated with poor prognosis
por: Xiong, Guosheng, et al.
Publicado: (2019)

Low expression of INMT is associated with poor prognosis but favorable immunotherapy response in lung adenocarcinoma
por: Zhou, Xincheng, et al.
Publicado: (2022)

High CTSL2 expression predicts poor prognosis in patients with lung adenocarcinoma
por: Song, Junnian, et al.
Publicado: (2021)

High DSCC1 Level Predicts Poor Prognosis of Lung Adenocarcinoma
por: Chang, Sisi, et al.
Publicado: (2021)

High expression of RRM2 as an independent predictive factor of poor prognosis in patients with lung adenocarcinoma
por: Jin, Cheng-Yu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q84rm7555bqv7l4nucc7qn5q9c